Sesh Sundararaman, MD, PhD, discusses his findings and how this approach can be triggered to minimize undesirable treatment features and open the door to newer treatment possibilities.
Sesh Sundararaman, MD, PhD
Advertisement
Sundararaman is an attending physician with the Division of Infectious Diseases at the Children’s Hospital of Philadelphia (CHOP).
Articles by Sesh Sundararaman, MD, PhD
Advertisement
Latest Updated Articles
How a Prodrug Approach May Aid In Antimalarial DevelopmentMarch 21st 2025
Advertisement
Advertisement
Trending on Contagion Live
1
Screwworm: The Flesh-Eating Parasite Returning to the Spotlight
2
Bepirovirsen Phase 3 Results Offer Potential Cure for Chronic Hepatitis B
3
Reductions in Funding, Personnel Will Leave US Less Prepared for Future Infectious Disease Outbreaks
4
FDA Approves Tebipenem Pivoxil as First Oral Carbapenem For Complicated Urinary Tract Infections
5